Skip to Main Navigation

Nepal: COVID-19 Emergency Response and Health Systems Preparedness Project

Abstract*

The purpose of the COVID-19 Emergency Response and Preparedness Project in Nepal is to prevent, detect and respond to the threat posed by COVID-19 (Coronavirus) and to strengthen national systems for public health preparedness. This project consists of four components. Component one will provide immediate support to prevent COVID-19 (Coronavirus) from arriving or limiting local transmission through containment strategies. There are two subcomponents:...

* The project abstract is drawn from the PAD, SAR or PGD and may not accurately reflect the project's current nature

Show More

Development Objective

The project development objective is to prevent, detect and respond to the threat posed by COVID-19 and to strengthen national systems for public health preparedness in Nepal.

Key Details

Project Details

  • P173760

  • Closed

  • Anna Koziel

  • Government of Nepal

  • Nepal

  • (as of board presentation)

    April 3, 2020

  • US$ 29.00 million

  • Ministry of Health and Population

  • South Asia

  • 2020

  • US$ 104.00 million

  • N/A

  • May 1, 2024

  • July 15, 2024

  • BANK APPROVED

  • Notes

Finances

Financing Plan (US$ Millions)

No data available.
Financier Commitments
IDA Credit 104.00

Total Project Financing (US$ Millions)

Product Line IBRD/IDA
IBRD Commitment N/A
IDA Commitment 104.00
IBRD + IDA Commitment 104.00
Lending Instrument
Grant Amount N/A
Total Project Cost** 29.00

Summary Status of World Bank Financing (US$ Millions) as of December 31, 2024

Download:
No data available.
Financier Approval Date Closing Date Principal Disbursed Repayments Interest, Charges & Fees

Detailed Financial Activity as of December 31, 2024

Download:
No data available.
Period Financier Transaction Type Amount (US$)
Apr 1, 2023 IDA-66040 Int Charges 100,801.54
Apr 1, 2023 IDA-66040 Int Charges 100,801.54
Apr 1, 2023 IDA-66040 Int Charges 3,207.30
Apr 1, 2023 IDA-66040 Int Charges 3,207.30
Oct 11, 2022 IDA-66040 Loan Disb 1,567,286.90
Oct 1, 2023 IDA-66040 Int Charges 487.87
Oct 1, 2023 IDA-66040 Int Charges 487.87
Oct 1, 2023 IDA-68470 Int Charges 471.88
Oct 1, 2023 IDA-68470 Int Charges 471.88
Oct 1, 2023 IDA-66040 Int Charges 101,518.49
Oct 1, 2023 IDA-66040 Int Charges 101,518.49
Oct 1, 2023 IDA-68470 Int Charges 122,971.39
Oct 1, 2023 IDA-68470 Int Charges 122,971.39
Jul 21, 2023 IDA-70280 Loan Cancel 17,000,000.00
Apr 3, 2020 IDA-66040 Loan Commitment 29,000,000.00
Jan 12, 2022 IDA-70280 Loan Commitment 18,000,000.00
Mar 18, 2021 IDA-68470 Loan Commitment 75,000,000.00
Apr 29, 2024 IDA-68470 Loan Cancel 17,400,000.00
Apr 1, 2024 IDA-68470 Int Charges 126,052.75
Apr 1, 2024 IDA-68470 Int Charges 126,052.75
Apr 1, 2024 IDA-68470 Int Charges 2,321.52
Apr 1, 2024 IDA-68470 Int Charges 2,321.52
Apr 1, 2024 IDA-66040 Int Charges 1,918.38
Apr 1, 2024 IDA-66040 Int Charges 1,918.38
Apr 1, 2024 IDA-70280 Int Charges -15,365.05
Apr 1, 2024 IDA-70280 Int Charges 15,365.05
Apr 1, 2024 IDA-66040 Int Charges 100,762.86
Apr 1, 2024 IDA-66040 Int Charges 100,762.86
Jul 14, 2020 IDA-66040 Loan Disb 7,430,385.50
May 26, 2020 IDA-66040 Loan Disb 5,800,000.00
Jul 26, 2021 IDA-66040 Loan Disb 1,407,500.00
Feb 11, 2021 IDA-66040 Loan Disb 1,904,240.50
Dec 16, 2020 IDA-66040 Loan Disb 1,809,966.20
Aug 20, 2020 IDA-66040 Loan Disb 1,092,500.00
Oct 1, 2020 IDA-66040 Int Charges 27,793.86
Oct 1, 2020 IDA-66040 Int Charges 27,793.86
Apr 15, 2021 IDA-66040 Loan Disb -2,047.13
Aug 12, 2021 IDA-68470 Loan Disb 10,002,000.00
Oct 1, 2021 IDA-66040 Int Charges 1,027.11
Oct 1, 2021 IDA-66040 Int Charges 1,027.11
Oct 1, 2021 IDA-66040 Int Charges 78,974.21
Oct 1, 2021 IDA-66040 Int Charges 78,974.21
Apr 1, 2021 IDA-66040 Int Charges 885.46
Apr 1, 2021 IDA-66040 Int Charges 885.46
Apr 1, 2021 IDA-66040 Int Charges 59,978.66
Apr 1, 2021 IDA-66040 Int Charges 59,978.66
Jun 30, 2021 IDA-66040 Loan Disb 4,517,378.00
Jan 14, 2022 IDA-66040 Loan Disb -97,480.97
Dec 20, 2021 IDA-68470 Loan Disb 33,606,720.00
Apr 1, 2022 IDA-66040 Int Charges 968.50
Apr 18, 2022 IDA-66040 Loan Disb 2,368,210.20
Aug 15, 2022 IDA-68470 Loan Disb -14,759,721.00
Jun 3, 2022 IDA-66040 Loan Disb 914,231.10
Apr 1, 2022 IDA-68470 Int Charges 9,924.23
Apr 1, 2022 IDA-68470 Int Charges 9,924.23
Apr 1, 2022 IDA-68470 Int Charges 106,389.78
Apr 1, 2022 IDA-68470 Int Charges 106,389.78
Apr 1, 2022 IDA-66040 Int Charges 87,480.70
Apr 1, 2022 IDA-66040 Int Charges 87,480.70
Apr 1, 2022 IDA-66040 Int Charges 968.50
Apr 27, 2023 IDA-68470 Loan Disb 1,600,000.00
Apr 26, 2023 IDA-68470 Loan Disb 6,400,000.00
Apr 1, 2023 IDA-68470 Int Charges 81,650.87
Oct 1, 2022 IDA-66040 Int Charges 1,126.45
Oct 1, 2022 IDA-66040 Int Charges 1,126.45
Oct 1, 2022 IDA-68470 Int Charges 134,169.73
Oct 1, 2022 IDA-68470 Int Charges 134,169.73
Oct 1, 2022 IDA-68470 Int Charges 1,481.33
Oct 1, 2022 IDA-68470 Int Charges 1,481.33
Oct 1, 2022 IDA-66040 Int Charges 90,359.18
Oct 1, 2022 IDA-66040 Int Charges 90,359.18
Apr 1, 2023 IDA-68470 Int Charges 18,947.09
Apr 1, 2023 IDA-68470 Int Charges 18,947.09
Apr 1, 2023 IDA-68470 Int Charges 81,650.87

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name Review Date
Progress towards achievement of PDO Satisfactory 2024-06-19
Project Management Moderately Satisfactory 2024-06-19
Monitoring and Evaluation Satisfactory 2024-06-19
Procurement Moderately Satisfactory 2024-06-19
Financial Management Moderately Satisfactory 2024-06-19
Overall Implementation Progress (IP) Moderately Satisfactory 2024-06-19

COMPLETION RATINGS

No data available.

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATORBASELINECURRENTTARGET
  • Proportion of prioritized population fully vaccinated, as per protocol, disaggregated by genderValue0.0096.3050.00
    DateJanuary 1, 2021February 15, 2024July 15, 2024
    Comment
  • Proportion of prioritized female population fully vaccinated, as per protocolValue0.0053.4050.00
    DateJanuary 1, 2021February 15, 2024July 15, 2024
    Comment
  • Proportion of prioritized male population fully vaccinated, as per protocolValue0.0046.6050.00
    DateJanuary 1, 2021February 15, 2024July 15, 2024
    Comment
  • Proportion of cold chain capacity gaps filled.Value0.00746.3660.00
    DateJanuary 1, 2021February 15, 2024July 15, 2024
    Comment
  • Proportion of female community health volunteers fully vaccinated, as per protocolValue0.0093.0060.00
    DateJanuary 1, 2021February 15, 2024July 15, 2024
    Comment
  • Proportion of vaccination sites/outreach with at least one female health care provider/volunteerValue0.0093.6480.00
    DateJanuary 1, 2021February 15, 2024July 15, 2024
    Comment

INTERMEDIATE RESULTS INDICATORS

INDICATORBASELINECURRENTTARGET
  • M&E system established to monitor COVID-19 preparedness and response planValueNoYesYes
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • Number of health staff trained in infection prevention and control per MoHP approved protocolsValue0.0011899.001000.00
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • Symposium on surveillance, treatment and prophylaxis conductedValue0.006.004.00
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • Percentage of specimens submitted for SARS-COV2 laboratory testing and confirmed within WHO stipulated standard timeValue0.00100.0090.00
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • Nepal has contextualized its risk communication and community engagement strategiesValueNoYesYes
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • Joint supervision and monitoring visits conductedValue0.0010.004.00
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • Proportion of callers to COVID-19 helplines satisfied with support/services providedValue0.0079.2560.00
    DateJanuary 1, 2021February 15, 2024July 15, 2024
    Comment
  • Number of acute healthcare facilities with triage capacityValue1.0030.0010.00
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • Proportion of SEA/SH calls received by COVID-19 helplines referred to OCMC or Women’s Commission for appropriate supportValue0.00100.0080.00
    DateJanuary 1, 2021February 15, 2024July 15, 2024
    Comment
  • New/rehabilitated ICU beds established in the public hospitals for managing public health emergenciesValue0.002773.00135.00
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • Number of designated laboratories with staff trained to conduct COVID-19 diagnosisValue1.00110.0045.00
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • Nepal has activated its public Health Emergency Operations Centre or a coordination mechanism for COVID-19ValueNoYesYes
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • Nepal adopted personal and community non-pharmaceutical interventions (schools closures, telework and remote meetings, reduce/cancel mass gatheringsValueNoYesYes
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • Number of designated laboratories with COVID-19 diagnostic equipment, test kits, and reagentsValue1.00110.0045.00
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • Number of acute healthcare facilities with isolation capacityValue1.0078.0050.00
    DateJanuary 10, 2020February 15, 2024July 15, 2024
    Comment
  • A National Deployment and Vaccination Plan (NDVP) is approved and adoptedValueNoYesYes
    DateJanuary 1, 2021February 15, 2024July 15, 2024
    Comment